114 related articles for article (PubMed ID: 8853970)
41. 1991 cervical screening recommendations: a working group report.
Paul C; Bagshaw S; Bonita R; Durham G; Fitzgerald NW; Jones RW; Marshall B; McAvoy BR
N Z Med J; 1991 Jul; 104(915):291-5. PubMed ID: 1906587
[TBL] [Abstract][Full Text] [Related]
42. [Screening of cervical cancer, false negative vaginal smears].
Weintraub D
Rev Med Suisse Romande; 1997 Nov; 117(11):921. PubMed ID: 9471658
[No Abstract] [Full Text] [Related]
43. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Brown AD; Garber AM
JAMA; 1999 Jan; 281(4):347-53. PubMed ID: 9929088
[TBL] [Abstract][Full Text] [Related]
44. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
45. [Screening for cervix cancer can be more effective. Many lives can be saved if risk patients are included].
Andersson S
Lakartidningen; 2011 Mar 9-15; 108(10):528-9. PubMed ID: 21744552
[No Abstract] [Full Text] [Related]
46. Reasons that some screening programmes fail to control cervical cancer.
Chamberlain J
IARC Sci Publ; 1986; (76):161-8. PubMed ID: 3570402
[No Abstract] [Full Text] [Related]
47. [Cervical cancer screening. False negative smears].
Vassilakos P; De Marval F; Muñoz M
Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
[No Abstract] [Full Text] [Related]
48. Cost-effectiveness of cervical cancer screening: comparison of screening policies.
van den Akker-van Marle ME; van Ballegooijen M; van Oortmarssen GJ; Boer R; Habbema JD
J Natl Cancer Inst; 2002 Feb; 94(3):193-204. PubMed ID: 11830609
[TBL] [Abstract][Full Text] [Related]
49. Cervical smears--an opportunity for disinvestment?
Spence MT; Woodman C; Collins S; Donnelly B; Desai M
Br J Gen Pract; 1996 Sep; 46(410):537-8. PubMed ID: 8917874
[TBL] [Abstract][Full Text] [Related]
50. Papanicolaou testing: when does more become less?
Sawaya GF
Am J Med; 2005 Feb; 118(2):159-60. PubMed ID: 15694901
[No Abstract] [Full Text] [Related]
51. [Cost-benefit of expanding cervical cancer screening].
Deng J; Tan H; Yang T; Huang X; Zhou S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):470-5. PubMed ID: 20543471
[TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness of cervical-cancer screening in developing countries.
Suba EJ; Frable WJ; Raab SS
N Engl J Med; 2006 Apr; 354(14):1535-6; author reply 1535-6. PubMed ID: 16598056
[No Abstract] [Full Text] [Related]
53. Improving uptake of cervical cancer screening in women with prolonged history of non-attendance for screening: a randomized trial of enhanced invitation methods.
Stein K; Lewendon G; Jenkins R; Davis C
J Med Screen; 2005; 12(4):185-9. PubMed ID: 16417695
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
[TBL] [Abstract][Full Text] [Related]
55. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
Boer R; de Koning H; Threlfall A; Warmerdam P; Street A; Friedman E; Woodman C
BMJ; 1998 Aug; 317(7155):376-9. PubMed ID: 9694752
[TBL] [Abstract][Full Text] [Related]
56. Measurement of the cost of screening for cervical cancer in the district of Florence, Italy.
Zappa M; Cecchini S; Ciatto S; Iossa A; Falini P; Mancini M; Paci E
Tumori; 1998; 84(6):631-5. PubMed ID: 10080666
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness of a cancer control programme.
Knox EG; Woodman CB
Cancer Surv; 1988; 7(3):379-401. PubMed ID: 3242791
[No Abstract] [Full Text] [Related]
58. Visualizing cost-effectiveness analysis.
Mark DH
JAMA; 2002 May; 287(18):2428-9. PubMed ID: 11988064
[No Abstract] [Full Text] [Related]
59. Clinical inquiries. Should we discontinue Pap smear screening in women aged>65 years?
Curran DR; Stigleman S; Neher JO
J Fam Pract; 2004 Apr; 53(4):308-10. PubMed ID: 15068776
[No Abstract] [Full Text] [Related]
60. Screening for cervical cancer: will women accept less?
Sirovich BE; Woloshin S; Schwartz LM
Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
